. 2001 May 1;19(9):2579-80; author reply 2580-2.
doi: 10.1200/JCO.2001.19.9.2579.
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
- PMID: 11331344
- DOI: 10.1200/JCO.2001.19.9.2579
Item in Clipboard
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
J Clin Oncol.
.
No abstract available
Similar articles
-
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?J Clin Oncol. 2001 May 1;19(9):2580; author reply 2580-2. doi: 10.1200/JCO.2001.19.9.2580. J Clin Oncol. 2001. PMID: 11331346 No abstract available.
-
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?J Clin Oncol. 2001 May 1;19(9):2578-9; author reply 2580-2. doi: 10.1200/JCO.2001.19.9.2578. J Clin Oncol. 2001. PMID: 11331342 No abstract available.
-
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?J Clin Oncol. 2001 May 1;19(9):2578; author reply 2580-2. J Clin Oncol. 2001. PMID: 11331341 No abstract available.
-
Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.Oncology. 2006;70(1):1-12. doi: 10.1159/000091180. Epub 2006 Jan 26. Oncology. 2006. PMID: 16439860 Review.
-
Focus on anastrozole and breast cancer.Curr Med Res Opin. 2003;19(8):683-8. doi: 10.1185/030079903125002397. Curr Med Res Opin. 2003. PMID: 14687437 Review.
Cited by
-
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.Br J Cancer. 2006 Jun 19;94(12):1789-96. doi: 10.1038/sj.bjc.6603194. Epub 2006 May 30. Br J Cancer. 2006. PMID: 16736002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
